• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM Back to Search Results
Model Number NX1000-3
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Hypovolemia (2243); Loss of consciousness (2418); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 06/26/2021
Event Type  Injury  
Manufacturer Narrative
The device was received for evaluation and successfully passed testing with no malfunction identified.A review of the device history record (dhr) was conducted which confirmed that the device met all quality criteria and manufacturing specifications prior to release.The nxstage system one user guide outlines risks associated with performing hemodialysis therapy and warns that treatment should only be performed by a trained and qualified person who must respond promptly to harmful conditions during treatment, check the system for blood and fluid leaks during treatment and pay close attention to the bloodline and access connections.Udi: (b)(4).
 
Event Description
A report was received on 29 june 2021 from the caregiver (cg) of a (b)(6) year old male patient with a medical history of diabetes, coronary artery disease, and end stage renal disease, stating the patient was found unresponsive with blood on the floor (amount not specified) and a dislodged dialysis needle on (b)(6) 2021.Additional information was received on 30 june 2021 from the home therapy nurse (htn) who stated emergency services were called, the patient was taken to hospital and admitted overnight.Hemoglobin was 11.9g/dl on admission, falling to 9.7g/dl and 8.7g/dl while in hospital.The patient stabilized with unspecified intravenous fluids and ¿further treatment for hypovolemia due to acute blood loss¿, and was discharged from hospital the following day, (b)(6) 2021 to continue using the nxstage system one for hemodialysis therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NXSTAGE SYSTEM ONE
Type of Device
HIGH PERMEABILITY HEMODIALYSIS SYSTEM
Manufacturer (Section D)
NXSTAGE MEDICAL, INC.
350 merrimack street
lawrence MA 01843
Manufacturer (Section G)
MEDIMEXICO S. DE R. L. DE C. V
av. valle imperial no. 10523
parque industrial valle sur
tijuana 22180
MX   22180
Manufacturer Contact
paula rogalski
nxstage medical, inc.
350 merrimack street
lawrence, MA 01843
MDR Report Key12195924
MDR Text Key262510395
Report Number3003464075-2021-00034
Device Sequence Number1
Product Code KDI
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K122051
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 07/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberNX1000-3
Device Catalogue NumberCHRONIC HI-FLOW CYCLER
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/14/2021
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/29/2021
Initial Date FDA Received07/20/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/07/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
Patient Weight92
-
-